Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abbreviated, acquiree, Africa, Ahmedabad, Alaia, allegedly, Amplity, analog, APA, Art, AstraZeneca, Aurobindo, authentication, automated, Automotive, Avery, Barr, Basel, BeiGene, Belfast, Biotie, BlackRock, Brownian, BRP, built, Cadila, Caltech, Cardinal, Cardiology, Cardiovascular, Carnegie, Celgene, CEO, Cerimon, charitable, China, Chinese, Christine, Circassia, civic, CMO, Commissioner, complementary, Composite, constitute, contributory, convince, convincing, coordinating, Council, Crucell, cum, Dale, decade, deceptive, dedicated, degradation, Dennison, Deputy, difficulty, diligence, diminished, disadvantage, discreet, disinterested, DME, doctorate, downturn, Dreamboat, durable, East, Edge, EEA, elevated, email, Endocyte, entry, ESG, Estate, EWBC, exacerbated, exceeded, exert, extreme, Fluor, founder, Fremont, Geometric, geopolitical, GlaxoSmithKline, Glenmark, Grancio, graph, Grumman, GSK, Hagerty, Harvest, harvesting, headquartered, Hollywood, Hope, Hyderabad, Immodulon, Impopharma, incurrence, Indore, inflationary, infusion, intercontinental, IRA, Jennifer, Kay, Kent, Kirin, Kresa, Kyowa, laude, led, Lederle, Leyden, Lincoln, LM, Louisiana, Lupin, magna, managerial, Marlborough, Marshall, mechanical, Metropolitan, Mid, misrepresentative, Monsanto, Mortgage, Mundkur, Museum, Nephew, Northrop, NV, outpace, Parenteral, PDA, penalize, Petersen, Pharm, Pharmacia, PharmD, philanthropist, pilot, Piramal, plc, Portal, postgraduate, predecessor, Premier, preset, pretax, ProQR, qualification, quantity, Queen, real, rejoined, relocate, resurgence, retaliatory, retention, RFP, Royal, Russia, Sabrina, Sanjay, sat, Searle, seller, Singh, Sixteen, slower, Smith, Southern, Southwestern, spearheaded, spray, Sr, staffed, Stanford, sterilization, Sterling, subset, substantive, suggest, sunset, Switzerland, Synergy, threaten, Tulane, Ukraine, undergraduate, unstable, USA, USC, Wealth, wearable, Winthrop, wiretapping, worn, Wyeth, Zealand
Removed:
accommodate, adherence, Admelog, adult, Aerami, allocable, AMSL, anionic, anniversary, announced, Apidra, apportioned, aspart, ASU, Australasian, authorization, Biomedical, Brexit, cationic, compliant, Conference, consultation, curtailing, deductibility, delaying, driven, effecting, encompassing, enrolled, expired, Facebook, Federation, Fiasp, formal, forward, frequent, globally, glulisine, Hall, handheld, Humalog, hydrophilic, hydrophobic, importance, inactivated, indefinitely, inform, Instagram, investigative, jeopardy, left, lending, licensure, lispro, master, measurable, media, minute, negotiating, nondeductible, Novolog, OPDP, oversee, peak, pharmacokinetic, phased, Poverty, proactive, profile, promise, question, randomized, recall, reducing, referendum, regained, retained, reverse, satisfaction, semiannually, Seton, split, subordinated, sum, temporarily, therapy, trend, Twitter, unavailable, unused, versatile, widespread, withdraw
Filing tables
Filing exhibits
Associated MNKD transcripts
MNKD similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-182457, 333-188790, 333-213366, 333-225428, 333-226648, and 333-242367 on Form S-8, and Registration Statement No. 333-262981 on Form S-3 of our reports dated February 23, 2023, relating to the financial statements of MannKind Corporation and subsidiaries (“MannKind Corporation”) and the effectiveness of MannKind Corporation’s internal control over financial reporting appearing in this Annual Report on Form 10-K of MannKind Corporation for the year ended December 31, 2022.
/s/ Deloitte & Touche LLP
Los Angeles, CA
February 23, 2023